cholestyramine การใช้

• It can be controlled with medication such as cholestyramine.
• Cholestyramine, colestipol and colesevelam have all been used.
• Bile acid sequestrants such as cholestyramine can be effective in chronic diarrhea due to bile acid malabsorption.
• Like cholestyramine, colestipol works in the gut by trapping bile acids and preventing them from being reabsorbed.
• To increase the clearance theoretically, due to the similarities with digitoxin, cholestyramine, a bile salt, might help.
• And cholestyramine, a drug commonly used to lower cholesterol levels, may impair calcium absorption indirectly by interfering with vitamin D absorption.
• Cholestyramine, an ion exchange resin, is effective in binding both toxin A and B, slowing bowel motility, and helping prevent dehydration.
• If dietary treatment alone is insufficient, bile acid-binding resins ( e . g ., cholestyramine, colestipol ) could be considered.
• When these data were combined, 32 % of 1223 patients had a SeHCAT 7-day retention of less than 10 %, and 80 % of these reported a response to cholestyramine, a bile acid sequestrant.
• For those who need long-term drug treatment, Hulley said that two other kinds of cholesterol-lowering drugs, the resin cholestyramine and the vitamin niacin, appear less likely to have long-term adverse effects.
• Cholesterol is the main constituent of atheroma, the fatty lumps in the wall of dietary measures, such as a low-fat diet, and poorly tolerated medicines, such as clofibrate, cholestyramine, and nicotinic acid.
• Colesevelam can be used instead of cholestyramine in symptomatic chronic diarrhea due to bile salt malabsorption ( bile acid diarrhea ), which can be a primary condition, or secondary to Crohn's disease or the postcholecystectomy syndrome.
• Other dietary factors that can inhibit lycopene absorption include soluble fibers like pectin and gums, cholesterol-binding resins ( cholestyramine and others ) used to lower serum cholesterol and the fat substitute olestra, currently approved for use only in salty snack foods.
• Studies of a number of other agents including antidiarrheals, bismuth subsalicylate ( Pepto-Bismol ), mesalazine / mesalamine ( alone or in combination with cholestyramine ), systemic corticosteroids, cholestyramine, immunomodulators, and probiotics have shown to be less effective than budesonide for treating both forms of microscopic colitis.
• Studies of a number of other agents including antidiarrheals, bismuth subsalicylate ( Pepto-Bismol ), mesalazine / mesalamine ( alone or in combination with cholestyramine ), systemic corticosteroids, cholestyramine, immunomodulators, and probiotics have shown to be less effective than budesonide for treating both forms of microscopic colitis.
• Medications used in managing biliary reflux include bile acid sequestrants, particularly cholestyramine, which disrupt the circulation of bile in the digestive tract and sequester bile that would otherwise cause symptoms when refluxed; and prokinetic agents, to move material from the stomach to the small bowel more rapidly and prevent reflux.
• In a review of 18 studies of the use of SeHCAT testing in diarrhea-predominant irritable bowel syndrome patients, 32 % of 1223 patients had a SeHCAT 7-day retention of less than 10 %, and 80 % of these reported a response to cholestyramine, a bile acid sequestrant.
• Treatment for symptoms of PSC include therapies to relieve itching ( antipruritics ) ( e . g . the bile acid sequestrant ( cholestyramine ) ), antibiotics to treat episodes of acute cholangitis, and vitamin supplements, as people with PSC are often deficient in fat-soluble vitamins ( vitamin A, vitamin D, vitamin E, and vitamin K ).
• The older ones include bile acid sequestrants ( like cholestyramine, colestipol and colesevelam ), which lower LDL by 15 percent to 30 percent and raise HDL by 3 percent to 5 percent, but have no effect on triglycerides; fibric acids like gemfibrozil and fenofibrate, which lower LDL by 5 percent to 20 percent, raise HDL by 10 percent to 20 percent, and lower triglycerides by 20 percent to 50 percent; and nicotinic acid, which lowers LDL by 5 percent to 25 percent, raises HDL by 15 percent to 35 percent, and lowers triglycerides by 20 percent to 50 percent.